Vyvanse - 54868-6009-0 - (lisdexamfetamine dimesylate)

Alphabetical Index


Drug Information of Vyvanse

Product NDC: 54868-6009
Proprietary Name: Vyvanse
Non Proprietary Name: lisdexamfetamine dimesylate
Active Ingredient(s): 40    mg/1 & nbsp;   lisdexamfetamine dimesylate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Vyvanse

Product NDC: 54868-6009
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021977
Marketing Category: NDA
Start Marketing Date: 20090320

Package Information of Vyvanse

Package NDC: 54868-6009-0
Package Description: 10 CAPSULE in 1 BOTTLE (54868-6009-0)

NDC Information of Vyvanse

NDC Code 54868-6009-0
Proprietary Name Vyvanse
Package Description 10 CAPSULE in 1 BOTTLE (54868-6009-0)
Product NDC 54868-6009
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lisdexamfetamine dimesylate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20090320
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name LISDEXAMFETAMINE DIMESYLATE
Strength Number 40
Strength Unit mg/1
Pharmaceutical Classes Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]

Complete Information of Vyvanse


General Information